Announced today by GSK: VHIO joins five other international research centers of excellence as member of the Oncology Clinical and Translational Consortium (OCTC)

• GSK undertakes global consortium incorporating six prestigious cancer research centers

• The Oncology Clinical and Translational Consortium (OCTC) includes centers in the US, Canada, France, the Netherlands and Spain
 

• Projects will focus on oncology clinical trials including combination therapies, as well as translational research

For more information and to access GSK´s press release issued today please see ´Related´ below.
 

Related Posts